Egenskap
Headache
Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve.
Sammendrag
- Også kalt
- Headaches
- Kroppssystem
- Abnormality of the nervous system
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Headache, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test265 gener knyttet til Headache
Endringer i disse genene forårsaker sjeldne tilstander der Headache forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| BCAT2branched chain amino acid transaminase 2 | Alltid | I 1 tilstand |
| CST3cystatin C | Alltid | I 1 tilstand |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Alltid | I 1 tilstand |
| KLklotho | Alltid | I 1 tilstand |
| LIG3DNA ligase 3 | Alltid | I 1 tilstand |
| LRRC7leucine rich repeat containing 7 | Alltid | I 1 tilstand |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Alltid | I 1 tilstand |
| MCATmalonyl-CoA-acyl carrier protein transacylase | Alltid | I 1 tilstand |
| MECRmitochondrial trans-2-enoyl-CoA reductase | Alltid | I 2 tilstander |
| NLRP3NLR family pyrin domain containing 3 | Alltid | I 4 tilstander |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Alltid | I 1 tilstand |
| POLG2DNA polymerase gamma 2, accessory subunit | Alltid | I 1 tilstand |
| RRP12ribosomal RNA processing 12 homolog | Alltid | I 2 tilstander |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Alltid | I 2 tilstander |
| SLC25A4solute carrier family 25 member 4 | Alltid | I 1 tilstand |
| SOSTsclerostin | Alltid | I 3 tilstander |
| TNFRSF11ATNF receptor superfamily member 11a | Alltid | I 1 tilstand |
| TOP2BDNA topoisomerase II beta | Alltid | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Alltid | I 2 tilstander |
| ADA2adenosine deaminase 2 | Svært ofte (80–99 %) | I 3 tilstander |
| APPamyloid beta precursor protein | Svært ofte (80–99 %) | I 1 tilstand |
| CCM2CCM2 scaffold protein | Svært ofte (80–99 %) | I 3 tilstander |
| DKK1dickkopf Wnt signaling pathway inhibitor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| ELANEelastase, neutrophil expressed | Svært ofte (80–99 %) | I 1 tilstand |
| EPORerythropoietin receptor | Svært ofte (80–99 %) | I 2 tilstander |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 3 tilstander |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 3 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 2 tilstander |
| JAK2Janus kinase 2 | Svært ofte (80–99 %) | I 4 tilstander |
| KRIT1KRIT1 ankyrin repeat containing | Svært ofte (80–99 %) | I 2 tilstander |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Svært ofte (80–99 %) | I 1 tilstand |
| PDCD10programmed cell death 10 | Svært ofte (80–99 %) | I 3 tilstander |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Svært ofte (80–99 %) | I 2 tilstander |
| PTENphosphatase and tensin homolog | Svært ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 3 tilstander |
| SLC19A2solute carrier family 19 member 2 | Svært ofte (80–99 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Ofte (30–79 %) | I 2 tilstander |
| AKT1AKT serine/threonine kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Ofte (30–79 %) | I 1 tilstand |
Vis 225 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Ofte (30–79 %) | I 3 tilstander |
| C1Rcomplement C1r | Ofte (30–79 %) | I 1 tilstand |
| C1Scomplement C1s | Ofte (30–79 %) | I 1 tilstand |
| C4Acomplement C4A (Chido/Rodgers blood group) | Ofte (30–79 %) | I 1 tilstand |
| CALRcalreticulin | Ofte (30–79 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| CD46CD46 molecule | Ofte (30–79 %) | I 1 tilstand |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 3 tilstander |
| CFHcomplement factor H | Ofte (30–79 %) | I 1 tilstand |
| CFIcomplement factor I | Ofte (30–79 %) | I 1 tilstand |
| CLCN2chloride voltage-gated channel 2 | Ofte (30–79 %) | I 2 tilstander |
| CMPK2cytidine/uridine monophosphate kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| CPT2carnitine palmitoyltransferase 2 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| EPM2AEPM2A glucan phosphatase, laforin | Ofte (30–79 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Ofte (30–79 %) | I 1 tilstand |
| GCDHglutaryl-CoA dehydrogenase | Ofte (30–79 %) | I 1 tilstand |
| GDF3growth differentiation factor 3 | Ofte (30–79 %) | I 1 tilstand |
| GDF6growth differentiation factor 6 | Ofte (30–79 %) | I 1 tilstand |
| GNAQG protein subunit alpha q | Ofte (30–79 %) | I 1 tilstand |
| GPR101G protein-coupled receptor 101 | Ofte (30–79 %) | I 2 tilstander |
| HELLPARHELLP associated long non-coding RNA | Ofte (30–79 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| IL10interleukin 10 | Ofte (30–79 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Ofte (30–79 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Ofte (30–79 %) | I 1 tilstand |
| IRF3interferon regulatory factor 3 | Ofte (30–79 %) | I 1 tilstand |
| JAM2junctional adhesion molecule 2 | Ofte (30–79 %) | I 1 tilstand |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Ofte (30–79 %) | I 2 tilstander |
| KITKIT proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 2 tilstander |
| KLRC4killer cell lectin like receptor C4 | Ofte (30–79 %) | I 1 tilstand |
| KYNUkynureninase | Ofte (30–79 %) | I 1 tilstand |
| LPIN2lipin 2 | Ofte (30–79 %) | I 1 tilstand |
| LRP6LDL receptor related protein 6 | Ofte (30–79 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Ofte (30–79 %) | I 2 tilstander |
| MEN1menin 1 | Ofte (30–79 %) | I 2 tilstander |
| MEOX1mesenchyme homeobox 1 | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Ofte (30–79 %) | I 2 tilstander |
| MRPS2mitochondrial ribosomal protein S2 | Ofte (30–79 %) | I 1 tilstand |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Ofte (30–79 %) | I 1 tilstand |
| MVKmevalonate kinase | Ofte (30–79 %) | I 1 tilstand |
| MYORGmyogenesis regulating glycosidase | Ofte (30–79 %) | I 1 tilstand |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 2 tilstander |
| NF2NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor | Ofte (30–79 %) | I 2 tilstander |
| NFE2L2NFE2 like bZIP transcription factor 2 | Ofte (30–79 %) | I 1 tilstand |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| NLRP12NLR family pyrin domain containing 12 | Ofte (30–79 %) | I 1 tilstand |
| NOTCH3notch receptor 3 | Ofte (30–79 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Ofte (30–79 %) | I 2 tilstander |
| PDGFRBplatelet derived growth factor receptor beta | Ofte (30–79 %) | I 1 tilstand |
| PFN1profilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Ofte (30–79 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| RYR1ryanodine receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| SH2B3SH2B adaptor protein 3 | Ofte (30–79 %) | I 2 tilstander |
| SLC20A2solute carrier family 20 member 2 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A1solute carrier family 2 member 1 | Ofte (30–79 %) | I 4 tilstander |
| SLC39A14solute carrier family 39 member 14 | Ofte (30–79 %) | I 1 tilstand |
| SMAD3SMAD family member 3 | Ofte (30–79 %) | I 1 tilstand |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Ofte (30–79 %) | I 1 tilstand |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Ofte (30–79 %) | I 1 tilstand |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Ofte (30–79 %) | I 1 tilstand |
| SMOsmoothened, frizzled class receptor | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Ofte (30–79 %) | I 2 tilstander |
| SUFUSUFU negative regulator of hedgehog signaling | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstander |
| THPOthrombopoietin | Ofte (30–79 %) | I 1 tilstand |
| TICAM1TIR domain containing adaptor molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| TLR3toll like receptor 3 | Ofte (30–79 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Ofte (30–79 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Ofte (30–79 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Ofte (30–79 %) | I 1 tilstand |
| TP53tumor protein p53 | Ofte (30–79 %) | I 3 tilstander |
| TRAF3TNF receptor associated factor 3 | Ofte (30–79 %) | I 1 tilstand |
| TRAF7TNF receptor associated factor 7 | Ofte (30–79 %) | I 1 tilstand |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Ofte (30–79 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| UNC93B1unc-93B1 regulator of TLR signaling | Ofte (30–79 %) | I 1 tilstand |
| VSX1visual system homeobox 1 | Ofte (30–79 %) | I 1 tilstand |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| ACP5acid phosphatase 5, tartrate resistant | Noen ganger (5–29 %) | I 1 tilstand |
| ACTA1actin alpha 1, skeletal muscle | Noen ganger (5–29 %) | I 1 tilstand |
| ACTN4actinin alpha 4 | Noen ganger (5–29 %) | I 1 tilstand |
| ADARadenosine deaminase RNA specific | Noen ganger (5–29 %) | I 1 tilstand |
| ADRA2Badrenoceptor alpha 2B | Noen ganger (5–29 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| ALX4ALX homeobox 4 | Noen ganger (5–29 %) | I 1 tilstand |
| AMER1APC membrane recruitment protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ANLNanillin, actin binding protein | Noen ganger (5–29 %) | I 1 tilstand |
| AP2S1adaptor related protein complex 2 subunit sigma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| APOL1apolipoprotein L1 | Noen ganger (5–29 %) | I 1 tilstand |
| ARHGAP24Rho GTPase activating protein 24 | Noen ganger (5–29 %) | I 1 tilstand |
| ARHGDIARho GDP dissociation inhibitor alpha | Noen ganger (5–29 %) | I 1 tilstand |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Noen ganger (5–29 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Noen ganger (5–29 %) | I 1 tilstand |
| AVILadvillin | Noen ganger (5–29 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Noen ganger (5–29 %) | I 1 tilstand |
| CACNA1Dcalcium voltage-gated channel subunit alpha1 D | Noen ganger (5–29 %) | I 1 tilstand |
| CBLIFcobalamin binding intrinsic factor | Noen ganger (5–29 %) | I 1 tilstand |
| CCND1cyclin D1 | Noen ganger (5–29 %) | I 1 tilstand |
| CD2APCD2 associated protein | Noen ganger (5–29 %) | I 1 tilstand |
| CDC73cell division cycle 73 | Noen ganger (5–29 %) | I 2 tilstander |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Noen ganger (5–29 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Noen ganger (5–29 %) | I 1 tilstand |
| CNNM2cyclin and CBS domain divalent metal cation transport mediator 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CNTN2contactin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| COL4A3collagen type IV alpha 3 chain | Noen ganger (5–29 %) | I 1 tilstand |
| COQ8Bcoenzyme Q8B | Noen ganger (5–29 %) | I 1 tilstand |
| CORINcorin, serine peptidase | Noen ganger (5–29 %) | I 1 tilstand |
| CRB2crumbs cell polarity complex component 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Noen ganger (5–29 %) | I 1 tilstand |
| CTNND2catenin delta 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CYP11B1cytochrome P450 family 11 subfamily B member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CYP11B2cytochrome P450 family 11 subfamily B member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| DAAM2dishevelled associated activator of morphogenesis 2 | Noen ganger (5–29 %) | I 1 tilstand |
| EMP2epithelial membrane protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| F8coagulation factor VIII | Noen ganger (5–29 %) | I 2 tilstander |
| FGFR2fibroblast growth factor receptor 2 | Noen ganger (5–29 %) | I 2 tilstander |
| FGFR3fibroblast growth factor receptor 3 | Noen ganger (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| FLT1fms related receptor tyrosine kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GNB2G protein subunit beta 2 | Noen ganger (5–29 %) | I 1 tilstand |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HTRA1HtrA serine peptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Noen ganger (5–29 %) | I 1 tilstand |
| INF2inverted formin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ITGA7integrin subunit alpha 7 | Noen ganger (5–29 %) | I 1 tilstand |
| KANK2KN motif and ankyrin repeat domains 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KIF23kinesin family member 23 | Noen ganger (5–29 %) | I 1 tilstand |
| LAMA5laminin subunit alpha 5 | Noen ganger (5–29 %) | I 1 tilstand |
| LRP5LDL receptor related protein 5 | Noen ganger (5–29 %) | I 2 tilstander |
| LSM11LSM11, U7 small nuclear RNA associated | Noen ganger (5–29 %) | I 1 tilstand |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Noen ganger (5–29 %) | I 1 tilstand |
| MARCHF6membrane associated ring-CH-type finger 6 | Noen ganger (5–29 %) | I 1 tilstand |
| MSX2msh homeobox 2 | Noen ganger (5–29 %) | I 3 tilstander |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MTHFRmethylenetetrahydrofolate reductase | Noen ganger (5–29 %) | I 1 tilstand |
| MYL2myosin light chain 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MYO1Emyosin IE | Noen ganger (5–29 %) | I 1 tilstand |
| NAGSN-acetylglutamate synthase | Noen ganger (5–29 %) | I 1 tilstand |
| NOTCH2notch receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| NPHS1NPHS1 adhesion molecule, nephrin | Noen ganger (5–29 %) | I 1 tilstand |
| NPHS2NPHS2 stomatin family member, podocin | Noen ganger (5–29 %) | I 1 tilstand |
| NPPAnatriuretic peptide A | Noen ganger (5–29 %) | I 1 tilstand |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Noen ganger (5–29 %) | I 1 tilstand |
| NUP107nucleoporin 107 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP133nucleoporin 133 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP160nucleoporin 160 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP205nucleoporin 205 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP37nucleoporin 37 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP85nucleoporin 85 | Noen ganger (5–29 %) | I 1 tilstand |
| NUP93nucleoporin 93 | Noen ganger (5–29 %) | I 1 tilstand |
| PAX2paired box 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PLCE1phospholipase C epsilon 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PRORPprotein only RNase P catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| PRTN3proteinase 3 | Noen ganger (5–29 %) | I 1 tilstand |
| PTPROprotein tyrosine phosphatase receptor type O | Noen ganger (5–29 %) | I 1 tilstand |
| RACGAP1Rac GTPase activating protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| RAPGEF2Rap guanine nucleotide exchange factor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| RASA1RAS p21 protein activator 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RETret proto-oncogene | Noen ganger (5–29 %) | I 1 tilstand |
| RHOBTB2Rho related BTB domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Aribonuclease H2 subunit A | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Bribonuclease H2 subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| RNASEH2Cribonuclease H2 subunit C | Noen ganger (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Noen ganger (5–29 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SAMD12sterile alpha motif domain containing 12 | Noen ganger (5–29 %) | I 1 tilstand |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Noen ganger (5–29 %) | I 2 tilstander |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Noen ganger (5–29 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| SDHCsuccinate dehydrogenase complex subunit C | Noen ganger (5–29 %) | I 1 tilstand |
| SELENONselenoprotein N | Noen ganger (5–29 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Noen ganger (5–29 %) | I 2 tilstander |
| SOX5SRY-box transcription factor 5 | Noen ganger (5–29 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| STOX1storkhead box 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TBC1D8BTBC1 domain family member 8B | Noen ganger (5–29 %) | I 1 tilstand |
| TNRC6Atrinucleotide repeat containing adaptor 6A | Noen ganger (5–29 %) | I 1 tilstand |
| TPM2tropomyosin 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TPM3tropomyosin 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Noen ganger (5–29 %) | I 1 tilstand |
| TWIST1twist family bHLH transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| USP48ubiquitin specific peptidase 48 | Noen ganger (5–29 %) | I 1 tilstand |
| USP8ubiquitin specific peptidase 8 | Noen ganger (5–29 %) | I 1 tilstand |
| WT1WT1 transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| YEATS2YEATS domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| ZEB2zinc finger E-box binding homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CASP10caspase 10 | Sjelden (1–4%) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjelden (1–4%) | I 1 tilstand |
| COL1A1collagen type I alpha 1 chain | Sjelden (1–4%) | I 1 tilstand |
| COL5A1collagen type V alpha 1 chain | Sjelden (1–4%) | I 1 tilstand |
| COL5A2collagen type V alpha 2 chain | Sjelden (1–4%) | I 1 tilstand |
| FASLGFas ligand | Sjelden (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjelden (1–4%) | I 1 tilstand |
| ANO1anoctamin 1 | Ikke registrert | I 1 tilstand |
| CYB5R3cytochrome b5 reductase 3 | Ikke registrert | I 1 tilstand |
| DNAI1dynein axonemal intermediate chain 1 | Ikke registrert | I 1 tilstand |
| MAOAmonoamine oxidase A | Ikke registrert | I 1 tilstand |
| TGFB1transforming growth factor beta 1 | Ikke registrert | I 1 tilstand |
| TTRtransthyretin | Ikke registrert | I 1 tilstand |
| VANGL1VANGL planar cell polarity protein 1 | Ikke registrert | I 1 tilstand |
| ZFHX2zinc finger homeobox 2 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker